ATE232529T1 - Substituierte 3-(aminoalkylamino)-1,2- benzisoxazole und verwandte verbindungen - Google Patents
Substituierte 3-(aminoalkylamino)-1,2- benzisoxazole und verwandte verbindungenInfo
- Publication number
- ATE232529T1 ATE232529T1 AT94902374T AT94902374T ATE232529T1 AT E232529 T1 ATE232529 T1 AT E232529T1 AT 94902374 T AT94902374 T AT 94902374T AT 94902374 T AT94902374 T AT 94902374T AT E232529 T1 ATE232529 T1 AT E232529T1
- Authority
- AT
- Austria
- Prior art keywords
- compounds
- benzisoxazoles
- aminoalkylamino
- substituted
- related compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
- C07D261/20—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Neurosurgery (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Psychiatry (AREA)
- Veterinary Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Pain & Pain Management (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US98002192A | 1992-11-23 | 1992-11-23 | |
| US08/150,301 US5494908A (en) | 1992-11-23 | 1993-11-12 | Substituted 3-(aminoalkylamino)-1,2-benzisoxazoles and related compounds |
| PCT/US1993/011416 WO1994012495A1 (en) | 1992-11-23 | 1993-11-22 | Substituted 3-(aminoalkylamino)-1,2-benzisoxazoles and related compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE232529T1 true ATE232529T1 (de) | 2003-02-15 |
Family
ID=26847521
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT94902374T ATE232529T1 (de) | 1992-11-23 | 1993-11-22 | Substituierte 3-(aminoalkylamino)-1,2- benzisoxazole und verwandte verbindungen |
Country Status (14)
| Country | Link |
|---|---|
| US (2) | US6046203A (de) |
| EP (1) | EP0669920B1 (de) |
| JP (1) | JP3462501B2 (de) |
| AT (1) | ATE232529T1 (de) |
| AU (1) | AU690529B2 (de) |
| CA (1) | CA2149918A1 (de) |
| DE (1) | DE69332691T2 (de) |
| DK (1) | DK0669920T3 (de) |
| ES (1) | ES2187518T3 (de) |
| FI (1) | FI952481L (de) |
| MX (1) | MX9307332A (de) |
| NO (1) | NO304980B1 (de) |
| NZ (1) | NZ258747A (de) |
| PT (1) | PT669920E (de) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5494908A (en) * | 1992-11-23 | 1996-02-27 | Hoechst-Roussel Pharmaceutical Incorporated | Substituted 3-(aminoalkylamino)-1,2-benzisoxazoles and related compounds |
| TWI310035B (en) * | 2000-04-28 | 2009-05-21 | Acadia Pharm Inc | Muscarinic agonists |
| EA012245B1 (ru) * | 2004-11-29 | 2009-08-28 | УОРНЕР-ЛАМБЕРТ КОМПАНИ Эд-Эл-Си | Терапевтические пиразоло[3,4-b]пиридины и индазолы |
| DE102005038947A1 (de) * | 2005-05-18 | 2006-11-30 | Grünenthal GmbH | Substituierte Benzo[d]isoxazol-3-yl-amin-Verbindungen und deren Verwendung in Arzneimitteln |
| KR20120123089A (ko) * | 2010-02-16 | 2012-11-07 | 화이자 인코포레이티드 | 5-HT₄ 수용체의 부분 효능제인 (R)-4-((4-((4-(테트라히드로푸란-3-일옥시)벤조[d]이속사졸-3-일옥시)메틸)피페리딘-1-일)메틸)테트라히드로-2H-피란-4-올 |
| ES2586213T3 (es) | 2011-10-31 | 2016-10-13 | Xenon Pharmaceuticals Inc. | Compuestos de bencenosulfonamida y su uso como agentes terapéuticos |
| MX2014005304A (es) | 2011-10-31 | 2015-03-20 | Xenon Pharmaceuticals Inc | Biaril eter sulfonamidas y su uso como agentes terapeuticos. |
| CA2874621A1 (en) | 2012-05-22 | 2013-11-28 | Genentech, Inc. | N-substituted benzamides and their use in the treatment of pain |
| US10071957B2 (en) | 2012-07-06 | 2018-09-11 | Genentech, Inc. | N-substituted benzamides and methods of use thereof |
| CN105263490B (zh) | 2013-03-14 | 2018-05-22 | 基因泰克公司 | 取代的三唑并吡啶及其使用方法 |
| CA2898680A1 (en) | 2013-03-15 | 2014-09-18 | Genentech,Inc. | Substituted benzoxazoles and methods of use thereof |
| JP6383418B2 (ja) | 2013-11-27 | 2018-08-29 | ジェネンテック, インコーポレイテッド | 置換ベンズアミド及びその使用方法 |
| CN106715418A (zh) | 2014-07-07 | 2017-05-24 | 基因泰克公司 | 治疗化合物及其使用方法 |
| MA42118A (fr) | 2015-05-22 | 2018-03-28 | Genentech Inc | Benzamides substitués et leurs méthodes d'utilisation |
| WO2017035271A1 (en) | 2015-08-27 | 2017-03-02 | Genentech, Inc. | Therapeutic compounds and methods of use thereof |
| JP6987746B2 (ja) | 2015-09-28 | 2022-01-05 | ジェネンテック, インコーポレイテッド | 治療用化合物及びその使用方法 |
| US10899732B2 (en) | 2015-11-25 | 2021-01-26 | Genentech, Inc. | Substituted benzamides useful as sodium channel blockers |
| US10766858B2 (en) | 2016-03-30 | 2020-09-08 | Genentech, Inc. | Substituted benzamides and methods of use thereof |
| BR112019007763A2 (pt) | 2016-10-17 | 2019-07-02 | Genentech Inc | composto de fórmula, composição farmacêutica, métodos para tratar uma doença ou condição, para tratar dores, para diminuir o fluxo de íons e para tratar prurido, uso de um composto e invenção |
| EP3601273B1 (de) | 2017-03-24 | 2021-12-01 | Genentech, Inc. | 4-piperidin-n-(pyrimidin-4-yl)chroman-7-sulfonamid-derivate als natriumkanalinhibitoren |
| AR114263A1 (es) | 2018-02-26 | 2020-08-12 | Genentech Inc | Compuestos terapéuticos y métodos para utilizarlos |
| WO2019191702A1 (en) | 2018-03-30 | 2019-10-03 | F. Hoffmann-La Roche Ag | Substituted hydro-pyrido-azines as sodium channel inhibitors |
| CN112204017B (zh) * | 2018-04-27 | 2024-08-20 | 国立大学法人大阪大学 | 苯并异噁唑化合物 |
| TW202003490A (zh) | 2018-05-22 | 2020-01-16 | 瑞士商赫孚孟拉羅股份公司 | 治療性化合物及其使用方法 |
| JP7594274B2 (ja) * | 2019-10-24 | 2024-12-04 | 国立大学法人大阪大学 | 難聴の予防および/または治療用医薬組成物 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3681382A (en) | 1969-02-07 | 1972-08-01 | Ciba Geigy Corp | 3-aminoindazoles |
| US3725431A (en) | 1970-09-23 | 1973-04-03 | Ciba Geigy Corp | 1-aralkyl-3-aminoindazoles |
| EP0090972B1 (de) * | 1982-03-17 | 1990-05-30 | Asahi Kasei Kogyo Kabushiki Kaisha | Indazol-Derivate |
| US4590196A (en) * | 1984-08-23 | 1986-05-20 | Bristol-Myers Company | Analgesic 1,2-benzisothiazol-3-ylpiperazine derivatives |
| US4999356A (en) * | 1987-08-07 | 1991-03-12 | Hoechst-Roussel Pharmaceuticals, Inc. | 1-phenyl-3-(1-piperazinyl)-1H-indazoles |
| EP0302423A3 (de) * | 1987-08-07 | 1991-01-09 | Hoechst-Roussel Pharmaceuticals Incorporated | 1-Phenyl-3-(1-piperazinyl)-1H-Indazole, Verfahren und Zwischenprodukte zu deren Herstellung und deren Anwendung als Arzneimittel |
| US5134236A (en) * | 1987-08-07 | 1992-07-28 | Hoechst-Roussel Pharmaceuticals Incorporated | Phenylhydrazones as intermediates 1-phenyl-3-(1-piperazenyl)-1H-indazoles |
| US5364866A (en) * | 1989-05-19 | 1994-11-15 | Hoechst-Roussel Pharmaceuticals, Inc. | Heteroarylpiperidines, pyrrolidines and piperazines and their use as antipsychotics and analetics |
| US4954503A (en) * | 1989-09-11 | 1990-09-04 | Hoechst-Roussel Pharmaceuticals, Inc. | 3-(1-substituted-4-piperazinyl)-1H-indazoles |
| FR2654104B1 (fr) * | 1989-11-07 | 1992-01-03 | Adir | Nouveaux derives du 1,2-benzisoxazole, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent. |
| US5147881A (en) * | 1990-11-14 | 1992-09-15 | Pfizer Inc | 4-(1,2-benzisoxazolyl)piperidine antipsychotic agents |
| PL171914B1 (pl) * | 1991-03-28 | 1997-06-30 | Eisai Co Ltd | Sposób wytwarzania pochodnych aminy heterocyklicznej PL PL PL PL PL PL PL |
-
1993
- 1993-11-22 JP JP51335294A patent/JP3462501B2/ja not_active Expired - Fee Related
- 1993-11-22 EP EP94902374A patent/EP0669920B1/de not_active Expired - Lifetime
- 1993-11-22 NZ NZ258747A patent/NZ258747A/en unknown
- 1993-11-22 DK DK94902374T patent/DK0669920T3/da active
- 1993-11-22 ES ES94902374T patent/ES2187518T3/es not_active Expired - Lifetime
- 1993-11-22 AU AU56765/94A patent/AU690529B2/en not_active Ceased
- 1993-11-22 PT PT94902374T patent/PT669920E/pt unknown
- 1993-11-22 CA CA002149918A patent/CA2149918A1/en not_active Abandoned
- 1993-11-22 AT AT94902374T patent/ATE232529T1/de not_active IP Right Cessation
- 1993-11-22 DE DE69332691T patent/DE69332691T2/de not_active Expired - Fee Related
- 1993-11-22 FI FI952481A patent/FI952481L/fi not_active IP Right Cessation
- 1993-11-23 MX MX9307332A patent/MX9307332A/es not_active Application Discontinuation
-
1995
- 1995-05-22 NO NO952018A patent/NO304980B1/no not_active IP Right Cessation
- 1995-06-06 US US08/471,197 patent/US6046203A/en not_active Expired - Lifetime
- 1995-06-06 US US08/470,520 patent/US5580982A/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| MX9307332A (es) | 1994-07-29 |
| US5580982A (en) | 1996-12-03 |
| EP0669920A1 (de) | 1995-09-06 |
| FI952481A0 (fi) | 1995-05-22 |
| DE69332691T2 (de) | 2003-12-18 |
| NO304980B1 (no) | 1999-03-15 |
| CA2149918A1 (en) | 1994-06-09 |
| EP0669920B1 (de) | 2003-02-12 |
| NO952018D0 (no) | 1995-05-22 |
| NO952018L (no) | 1995-05-22 |
| FI952481A7 (fi) | 1995-05-22 |
| JPH08506094A (ja) | 1996-07-02 |
| FI952481L (fi) | 1995-05-22 |
| EP0669920A4 (de) | 1995-10-25 |
| JP3462501B2 (ja) | 2003-11-05 |
| AU690529B2 (en) | 1998-04-30 |
| NZ258747A (en) | 1997-02-24 |
| US6046203A (en) | 2000-04-04 |
| ES2187518T3 (es) | 2003-06-16 |
| PT669920E (pt) | 2003-06-30 |
| AU5676594A (en) | 1994-06-22 |
| DE69332691D1 (de) | 2003-03-20 |
| DK0669920T3 (da) | 2003-05-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69332691D1 (de) | Substituierte 3-(aminoalkylamino)-1,2-benzisoxazole und verwandte verbindungen | |
| KR950704308A (ko) | 치환된 3-(아미노알킬아미노)-1,2-벤즈이속사졸 및 관련 화합물(Substituted) 3-(aminoalkylamino)-1,2-benzisoxazoles and related compounds) | |
| MY138252A (en) | Azabicyclic-substitud fused-heteroaryl compounds for the treatment of disease | |
| DE69418789D1 (de) | 2-(Piperidin-4-yl, Pyridin-4-yl und Tetrahydropyridin-4-yl)-benzofuran-7-carbamat Derivate, ihre Herstellung und Verwendung als Acetylcholinesterase Inhibitoren | |
| FI920192A0 (fi) | Substituerade 1,2,3,4-tetrahydro -cyklopent/b/indoler, 1,2,3,3a,4,8a-hexahydrocyklopent/b/indoler och motsvarande foereningar, mellanprodukter och foerfarande foer deras framstaellning och deras anvaendning som laekemedel. | |
| ATE121621T1 (de) | Verwendung von tetrahydrothienopyridinderivate als angiogenese-inhibitoren. | |
| FI922592A0 (fi) | (arylalkylpiperidin-4-yl)metyl)-2a,3, 4,5-tetra-hydro-1(2h)-acetnaftylen-1-oner och motsvarande foereningar, foerfarande foer deras framstaellning och deras anvaendning som laekemedel. | |
| NO955176D0 (no) | Benzenderivat nyttig for ischemiske sykdommer | |
| ATE130004T1 (de) | 3-(1,2-benzisoxazol-3-yl)-4-pyridinamine und derivate. | |
| DK0766695T3 (da) | Pyrrolidinderivater til behandling af CCK- og gastrinrelaterede sygdomme | |
| DK0401779T3 (da) | 4,5,5a,6-Tetrahydro-3H-isoazolo(5,4,3-kl)acridinderivater, en fremgangsmåde til deres fremstilling og deres anvendelse som lægemidler | |
| DE69610851D1 (de) | Disubstituierte piperidine-derivate | |
| DK0871611T3 (da) | Hidtil ukendte glycylanilidderivater, deres fremstilling og deres terapeutiske anvendelse | |
| DK460789A (da) | 2-aminoacetamidderivater |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |